Rubius Therapeutics Insider Trades

RUBY

Track insider trading activity from Rubius Therapeutics executives and directors. See which insiders are buying and selling RUBY stock.

Trades Last 12 Months

All Insider Trades for Rubius Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Appelhans Dannielle CEO And President
Holding Value $0 0 shares
Last Trade
Feb 24, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.35k 10,385 shares
$0.13
$0.06
Cagnoni Pablo J Director
Holding Value $3.77k 66,082 shares
Last Trade
Feb 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.11k 8,448 shares
$0.25
$0.06
Turka Laurence A. Chief Scientific Officer
Holding Value $1.05k 18,391 shares
Last Trade
Jan 31, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$622 2,593 shares
$0.24
$0.06
Holding Value $2.85k 50,000 shares
Last Trade
Jul 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.1k 50,000 shares
$0.70
$0.06
Afeyan Noubar Director
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Cuss Francis M Director
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Epstein David R Director
Holding Value $28.5k 499,762 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$620k 499,762 shares
$1.24
$0.06
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Prener Anne Director
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Symonds Jonathan Director
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Keson Brookes Maiken CLO & Corp. Secretary
Holding Value $305 5,343 shares
Last Trade
Feb 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.9k 2,732 shares
$6.57
$0.06
Carmona Jose Chief Financial Officer
Holding Value $8.19k 143,750 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$970k 143,750 shares
$6.75
$0.06
Holding Value $877k 15,393,593 shares
Last Trade
Mar 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.77M 70,000 shares
$25.31
$0.06
Keson Brookes Maiken CLO & Corp. Secretary
Holding Value $0 0 shares
Last Trade
Mar 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$757k 25,000 shares
$30.29
$0.06
Coughlin Christina M. Chief Medical Officer
Holding Value $8.12k 142,500 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 174,800 shares
$11.97
$0.06
Oh Andrew M. Chief Financial Officer
Holding Value $43.1k 755,500 shares
Last Trade
May 15, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28k 5,000 shares
$5.60
$0.06
Carpenter Christopher L. Chief Medical Officer
Holding Value $4.72k 82,843 shares
Last Trade
Dec 16, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$658k 48,000 shares
$13.71
$0.06
Langer Robert Director
Holding Value $428 7,500 shares
Last Trade
Oct 14, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$63.2k 7,500 shares
$8.42
$0.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up